Methods: We evaluated protein tyrosine kinase (PTK) gene expression profiles of primary leukemic cells in KMT2A/MLL-R+ AML and ALL patients using publicly available archived datasets. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.